Our Views Articles, views and insights from the ADAMAS team. Come and meet ADAMAS Consulting at the RQA European QA Conference, Belfast Date September 27, 2023 ADAMAS is thrilled to announce our presence at the RQA 2023 International QA Conference, taking place from the 1st to the 3rd of... Read More Computer Software Assurance (CSA): Why the Change and What Does it Mean? Date April 28, 2022 At this moment the FDA Center for Devices and Radiological Health (CDRH), in collaboration with the Center for Biologics Evaluation and Research (CBER)... Read More Annex 1 Revisions: What are the Changes and Whom will they Affect? Date April 13, 2022 The EU has released a draft version of Annex 1. Expected to be implemented either later this year (2022) or early next year,... Read More Why Is Data Integrity Important When Transferring Data in a Clinical Trial? Date March 28, 2022 This piece is an extract of the upcoming ADAMAS white paper “Making the Model: Solving the Data Integrity Challenge of Decentralized Clinical Trials”.... Read More ADAMAS and Ergomed combine to expand global capabilities Date February 9, 2022 I am delighted to share some exciting news released today about the acquisition of ADAMAS Consulting Group Limited by Ergomed plc which will allow... Read More ADAMAS Spotlight: Jean-Luc Salendre Date January 18, 2022 The diversity of our people, in skills, background and experience, is what gives ADAMAS its strength and ability to conduct ourselves with excellence... Read More Load More Loading More... You’ve reached the end of the list
Come and meet ADAMAS Consulting at the RQA European QA Conference, Belfast Date September 27, 2023 ADAMAS is thrilled to announce our presence at the RQA 2023 International QA Conference, taking place from the 1st to the 3rd of... Read More
Computer Software Assurance (CSA): Why the Change and What Does it Mean? Date April 28, 2022 At this moment the FDA Center for Devices and Radiological Health (CDRH), in collaboration with the Center for Biologics Evaluation and Research (CBER)... Read More
Annex 1 Revisions: What are the Changes and Whom will they Affect? Date April 13, 2022 The EU has released a draft version of Annex 1. Expected to be implemented either later this year (2022) or early next year,... Read More
Why Is Data Integrity Important When Transferring Data in a Clinical Trial? Date March 28, 2022 This piece is an extract of the upcoming ADAMAS white paper “Making the Model: Solving the Data Integrity Challenge of Decentralized Clinical Trials”.... Read More
ADAMAS and Ergomed combine to expand global capabilities Date February 9, 2022 I am delighted to share some exciting news released today about the acquisition of ADAMAS Consulting Group Limited by Ergomed plc which will allow... Read More
ADAMAS Spotlight: Jean-Luc Salendre Date January 18, 2022 The diversity of our people, in skills, background and experience, is what gives ADAMAS its strength and ability to conduct ourselves with excellence... Read More